A real-world comparison of commercial use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma.
Looka A, Qualls DA, Matthews D, Redd RA, Sakellis C, Duffy C, Dela Cruz J, Saucier A, Armand P, Crombie JL, Fisher DC, Jacobsen ED, Kim AI, LaCasce AS, Merryman RW, Parry EM, Jacobson CA.
Looka A, et al. Among authors: duffy c.
Blood Adv. 2024 Nov 15:bloodadvances.2024012992. doi: 10.1182/bloodadvances.2024012992. Online ahead of print.
Blood Adv. 2024.
PMID: 39546746